Dr. Reddy's Laboratories Limited (RDDA) — Cash Flow Quality Index
Dr. Reddy's Laboratories Limited (RDDA) has a Cash Flow Quality Index of 0.90x as of December 2025. Operating cash flow of €10.91 Billion is below net income of €12.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Dr. Reddy's Laboratories Limited long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Dr. Reddy's Laboratories Limited Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Dr. Reddy's Laboratories Limited across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Dr. Reddy's Laboratories Limited to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year earnings quality comparison for Dr. Reddy's Laboratories Limited. For live market cap and the full company financial profile, see Dr. Reddy's Laboratories Limited (RDDA) market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.82x | €46.43 Billion | €56.54 Billion | ▲ +0.8% |
| 2024 | 0.81x | €45.43 Billion | €55.78 Billion | ▼ -37.7% |
| 2023 | 1.31x | €58.88 Billion | €45.07 Billion | ▲ +9.5% |
| 2022 | 1.19x | €28.11 Billion | €23.57 Billion | ▼ -36.0% |
| 2021 | 1.86x | €35.70 Billion | €19.15 Billion | ▲ +21.8% |
| 2020 | 1.53x | €29.84 Billion | €19.50 Billion | ▲ +0.2% |
| 2019 | 1.53x | €28.70 Billion | €18.80 Billion | ▼ -16.9% |
| 2018 | 1.84x | €18.03 Billion | €9.81 Billion | ▲ +2.9% |
| 2017 | 1.79x | €21.51 Billion | €12.04 Billion | — |